DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
T••••• P••••••••• I••
Drug Discovery & Developmentgroup grade Aoff every schedule since Sep 30, 2024sponsor unattributed
Also written as: 2022; 5; 5/5/2022; Equity
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
102¢ · 103¢ · 105¢Q3 2023 to Q1 2024
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$2.6M
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Sep 30, 2024
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2024, folded to one row per lender
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| H••••••• C••••••• I••• | equity equity A••••••••• D••• 5/5/2022, Series C••••• S•••• | Not disclosed | $2.6M 244c |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2024 | at least $12.4M | 105c | S+445 bp | Feb 1, 2027 | 1 |
Equity pieces beside the debt: equity ($2.6M fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | $0 | $0 | n/a | 0 |
| Jun 30, 2024 | 1 | $0 | $0 | n/a | 0 |
| Mar 31, 2024 | 1 | $12.4M | $13.1M | 105c | 0 |
| Dec 31, 2023 | 1 | $37.1M | $38.7M | 103c | 0 |
All 8 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2023 | 1 | $12.4M | $12.7M | 102c | 0 |
| Jun 30, 2023 | 1 | $10.3M | $10.4M | 101c | 0 |
| Mar 31, 2023 | 1 | $10.3M | $10.4M | 100c | 0 |
| Dec 31, 2022 | 1 | $8.3M | $8.4M | 102c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2024
- Spread changed (observed)Mar 31, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- T••••• P•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Drug Discovery & Developmentreportedas one filer wrote it